Medigus Ltd (Israel) Performance

MDGS -- Israel Stock  

ILS 51.20  0.90  1.79%

On a scale of 0 to 100 Medigus Ltd holds performance score of 6. The company secures Beta (Market Risk) of -1.2131 which conveys that as returns on market increase, returns on owning Medigus Ltd are expected to decrease by larger amounts. On the other hand, during market turmoil, Medigus Ltd is expected to significantly outperform it. Although it is vital to follow to Medigus Ltd price patterns, it is good to be conservative about what you can actually do with the information regarding equity historical price patterns. The philosophy towards estimating future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. We have found twenty-one technical indicators for Medigus Ltd which you can use to evaluate performance of the firm. Please exercises Medigus Ltd Coefficient Of Variation, Variance and the relationship between Downside Deviation and Standard Deviation to make a quick decision on weather Medigus Ltd current price movements will revert.
Horizon     30 Days    Login   to change

Medigus Ltd Relative Risk vs. Return Landscape

If you would invest  4,630  in Medigus Ltd on February 21, 2019 and sell it today you would earn a total of  490.00  from holding Medigus Ltd or generate 10.58% return on investment over 30 days. Medigus Ltd is generating 0.5819% of daily returns and assumes 5.6192% volatility on return distribution over the 30 days horizon. Simply put, 50% of equities are less volatile than Medigus Ltd and 90% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
      Risk (%) 
Assuming 30 trading days horizon, Medigus Ltd is expected to generate 8.19 times more return on investment than the market. However, the company is 8.19 times more volatile than its market benchmark. It trades about 0.1 of its potential returns per unit of risk. The DOW is currently generating roughly 0.15 per unit of risk.

Medigus Ltd Market Risk Analysis

Sharpe Ratio = 0.1036
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsMDGS
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns

Medigus Ltd Relative Performance Indicators

Estimated Market Risk
 5.62
  actual daily
 
 50 %
of total potential
 
50
Expected Return
 0.58
  actual daily
 
 10 %
of total potential
 
10
Risk-Adjusted Return
 0.1
  actual daily
 
 6 %
of total potential
 
6
Based on monthly moving average Medigus Ltd is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medigus Ltd by adding it to a well-diversified portfolio.

Medigus Ltd Performance Rating

Medigus Ltd Risk Adjusted Performance Analysis

6

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Medigus Ltd are ranked lower than 6 (%) of all global equities and portfolios over the last 30 days.

Medigus Ltd Alerts

Equity Alerts and Improvement Suggestions

Medigus Ltd is not yet fully synchronised with the market data
Medigus Ltd appears to be very risky and stock price may revert if volatility continues
The company reported revenue of 492K. Net Loss for the year was (5.74M) with loss before overhead, payroll, taxes, and interest of (49K).
MEDIGUS has accumulated about 11.93M in cash with (3.86M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22.

Medigus Ltd Performance Indicators

Medigus Ltd Basic Price Performance Measures

Quick Ratio12.14
Fifty Two Week Low41.10
Target High Price1.50
Fifty Two Week High168.00
Target Low Price1.50
Please see also Stocks Correlation. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Search macroaxis.com